Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 9, 2005, Pages 3451-3457

  Michaelis, Martin ^a   Suhan, Tatyana ^a   Reinisch, Alexander ^a   Reisenauer, Agnes ^a   Fleckenstein, Corinna ^a   Eikel, Daniel ^b   Gümbel, Hermann ^c   Doerr, Hans Wilhelm ^a   Nau, Heinz ^b   Cinatl Jr , Jindrich ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c BUNDESWEHRKRANKENHAUS ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 PENTYL 4 PENTYNOIC ACID; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID; ENZYME INHIBITOR; VIRUS ANTIGEN;

ACETYLATION; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOHISTOCHEMISTRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION; VIRUS TITRATION; WESTERN BLOTTING; CELL CULTURE; CYTOMEGALOVIRUS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; VIROLOGY;

ACETYLATION; ANTIGENS, VIRAL; BLOTTING, WESTERN; CELLS, CULTURED; CYTOMEGALOVIRUS; ENZYME INHIBITORS; HISTONE DEACETYLASES; HISTONES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PIGMENT EPITHELIUM OF EYE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VALPROIC ACID; VIRUS REPLICATION;

EID: 27244442133     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0369     Document Type: Article

References (46)

1. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem. 2001;276:36734-36741.
2. Göttlicher M, Minucci S, Zhu P, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001;20:6969-6978.
3. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 2002;16:695-714.
4. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290:1467-1473.
5. Citrome L. Schizophrenia and valproate. Psychopharmacol Bull. 2003;37:74-88.
6. Belmaker RH. Bipolar disorder. N Engl J Med. 2004;351:476-486.
7. Frediani F. Anticonvulsant drugs in primary headaches prophylaxis. Neurol Sci. 2004;25:S161-S166.
8. Blaheta RA, Michaelis M, Hernáiz Driever P, Cinatl J Jr. The evolving anticancer drug valproic acid: insights into the mechanism and clinical studies. Med Res Rev January 6, 2005 (Epub ahead of print).
9. Michaelis M, Köhler N, Reinisch A, et al. Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid. Biochem Pharmacol. 2004;68:531-538.
10. Dunn HS, Haney DJ, Ghanekar SA, Stepick-Biek P, Lewis DB, Maecker HT. Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J Infect Dis. 2002;186:15-22.
11. Scholz M, Doerr HW. Cinatl J Jr. Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol. 2003;11:171-178.
12. Knipe DM, Howley PM. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:2675-2706.
13. Chiou SH, Liu JH, Chen SS, et al. Apoptosis of human retina and retinal pigment cells induced by human cytomegalovirus infection. Ophthalmic Res. 2002;34:77-82.
14. Detrick B, Rhame J, Wang Y, Nagineni CN, Hooks JJ. Cytomegalovirus replication in human retinal pigment epithelial cells: altered expression of viral early proteins. Invest Ophthalmol Vis Sci. 1996;37:814-825.
15. Cinatl J Jr, Blaheta R, Bittoova M, et al. Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis. J Immunol. 2000;165:4405-4413.
16. Cinatl J Jr, Margraf S, Vogel JU, Scholz M, Cinatl J, Doerr HW. Human cytomegalovirus circumvents NF-kappa B dependence in retinal pigment epithelial cells. J Immunol. 2001;167:1900-1908.
17. Chiou SH, Liu JH, Hsu WM, et al. Up-regulation of Fas ligand expression by human cytomegalovirus immediate-early gene product 2: a novel mechanism in cytomegalovirus-induced apoptosis in human retina. J Immunol. 2001;167:4098-4103.
18. Detrick B, Nagineni CN, Grillone LR, Anderson KP, Henry SP, Hooks JJ. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides. Invest Ophthalmol Vis Sci. 2001;42:163-169.
19. Snoeck R, Andrei G, Bodaghi B, et al. 2-Chloro-3-pyridin-3-yl-5,6,7,8- tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections. Antiviral Res. 2002;55:413-424.
20. Allart S, Lule J, Serres B, et al. Impaired killing of HCMV-infected retinal pigment epithelial cells by anti-pp65 CD8(+) cytotoxic T cells. Invest Ophthalmol Vis Sci. 2003;44:665-671.
21. Momma Y, Nagineni CN, Chin MS, Srinivasan K, Detrick B, Hooks JJ. Differential expression of chemokines by human retinal pigment epithelial cells infected with cytomegalovirus. Invest Ophthalmol Vis Sci. 2003;44:2026-2033.
22. Scholz M, Vogel JU, Höver G, et al. Thrombin stimulates IL-6 and IL-8 expression in cytomegalovirus-infected human retinal pigment epithelial cells. Int J Mol Med. 2004;13:327-331.
23. Blaheta RA, Nau H, Michaelis M, Cinatl J Jr. Valproate and valproate-analogues: potent tools to fight against cancer. Curr Med Chem. 2002;9:1417-1433.
24. Cho KS, Elizondo LI, Boerkoel CF. Advances in chromatin remodeling and human disease. Curr Opin Genet Dev. 2004;14:308-315.
25. Peterson CL, Laniel MA. Histones and histone modifications. Curr Biol. 2004;14:R546-R551.
26. Murphy JC, Fischle W, Verdin E, Sinclair JH. Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J. 2002;21:1112-1120.
27. Nevels M, Paulus C, Shenk T. Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc Natl Acad Sci USA. 2004;101:17234-17239.
28. Yuan PX, Huang LD, Jiang YM, Gutkind JS, Manji HK, Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem. 2001;276:31674-31683.
29. Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res. 2004;64:1079-1086.
30. Hao Y, Creson T, Zhang L, et al. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci. 2004;24:6590-6599.
31. Nau H, Hauck RS, Ehlers K. Valproic acid-induced neural tube defects in the mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacol Toxicol. 1991;69:310-321.
32. Bojic U, Ehlers K, Ellerbeck U, et al. Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre. Eur J Pharmacol. 1998;354:289-299.
33. Gravemann U. Synthesis of achiral, racemic and enantiomerically pure valproic acid derivatives with anticonvulsant, neurotoxic and teratogenic potency. Hannover, Germany: University of Hannover 2002. Thesis.
34. Cinatl J Jr, Kotchetkov R, Scholz M, et al. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Am J Pathol. 1999;155:285-292.
35. Cinatl J Jr, Cinatl J, Weber B, et al. In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate. Antiviral Res. 1995;27:405-418.
36. Cinatl J Jr, Hoffmann F, Cinatl J, et al. In vitro inhibition of human cytomegalovirus replication by calcium triatrium diethylenetriaminepentaacetic acid. Antiviral Res. 1996;31:23-34.
37. Thisted E, Ebbesen F. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch Dis Child. 1993;69:288-291.
38. Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med. 1996;334:168-175.
39. Chang F, Steelman LS, Shelton JG, et al. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. Int J Oncol. 2003;22:469-480.
40. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. MAPK pathways in radiation responses. Oncogene. 2003;22:5885-5896.
41. Kuntz-Simon G, Obert G. Sodium valproate, an anticonvulsant drug, stimulates human cytomegalovirus replication. J Gen Virol. 1995;76:1409-1415.
42. Dunn W, Chou C, Li H, et al. Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci USA. 2003;100:14223-14228.
43. Einat H, Yuan P, Gould TD, et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci. 2003;23:7311-7316.
44. Di Daniel E, Mudge AW, Maycox PR. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disord. 2005;7:33-41.
45. Conilleau V, Dompmartin A, Verneuil L, Michel M, Leroy D. Hypersensitivity syndrome due to 2 anticonvulsant drugs. Contact Dermatitis. 1999;41:141-144.
46. Jennings HR, Romanelli F. The use of valproic acid in HIV-positive patients. Ann Pharmacother. 1999;33:1113-1116.